ALEC Alector, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 6, 2026
$1.81
· % 处于52周区间
· 高于低点
· 至高点
$1.0952周低点
$3.4052周高点
市值 (MRQ)
$202M
P/E (TTM)
-1.6
EPS (TTM)
$-1.10
收入 (TTM)
$14M
ALEC 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.81
市值 (MRQ)
$202M
P/E (TTM)
-1.6
EPS (TTM)
$-1.10
收入 (TTM)
$14M
ROE (TTM)
-385.1%
负债/权益 (MRQ)
-1.0
52周区间
$1–$3
ALEC 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Alector, Inc. - Common Stock 公司概况（来自维基百科）
行业板块Healthcare
行业Biotechnology
员工103
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$21M2017-12-31 → 2025-12-31
EPS$-1.392020-12-31 → 2025-12-31
自由现金流$-184M2019-12-31 → 2025-12-31
净利率-851.7%2019-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ALEC | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -1.65年均值 ≈-11.9 | ≈-11.9 | · | · | |
| P/S (TTM) | 14.65年均值 ≈6.1 | ≈6.1 | 16.0 | 估值过高 | |
| 市净率 (MRQ) | -20.35年均值 ≈4.2 | ≈4.2 | · | · | |
| EV / EBITDA (企业价值 / EBITDA) | 0.3 | · | · | · | |
| 股价/自由现金流 (TTM) | -1.35年均值 ≈-6.2 | ≈-6.2 | · | · | |
| 市现率 (TTM) | -1.35年均值 ≈-7.4 | ≈-7.4 | · | · | |
| 市值/营收 (TTM) | 2.8 | · | · | · | |
| 市值/自由现金流 (TTM) | -0.2 | · | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 6.65年均值 ≈4.2 | ≈4.2 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ALEC | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -914.1%5年均值 ≈-232.6% | ≈-232.6% | -1357.2% | 顶尖 | |
| EBITDA Margin (息税折旧摊销前利润率) | -741.3%5年均值 ≈-232.6% | ≈-232.6% | -1356.6% | 顶尖 | |
| 税前利润率 (TTM) | -849.4% | · | -1167.4% | 顶尖 | |
| 净利润率 (TTM) | -851.7%5年均值 ≈-209.8% | ≈-209.8% | -1615.2% | 顶尖 | |
| ROA (TTM) | -42.1%5年均值 ≈-20.0% | ≈-20.0% | -24.7% | 弱 | |
| ROE (TTM) | -385.1%5年均值 ≈-106.8% | ≈-106.8% | -24.6% | 弱 | |
| ROIC | -387.2% | · | -51.5% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ALEC | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | -1.0 | · | -0.2 | 低负债 | |
| 流动比率 (MRQ) | 5.35年均值 ≈4.7 | ≈4.7 | 7.9 | 低流动性 | |
| Quick Ratio (速动比率) | 3.75年均值 ≈4.6 | ≈4.6 | 7.4 | 低流动性 | |
| 长期负债/股东权益 (MRQ) | -0.0 | · | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ALEC | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -79.1%5年均值 ≈148.6% | ≈148.6% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -46.0%5年均值 ≈-0.35% | ≈-0.35% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -0.05% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ALEC | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.15年均值 ≈0.2 | ≈0.2 | 0.1 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$204.3K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
22.4%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 5, 2026 | $-0.21 | $-0.23 | 9.7% |
| 2026年3月31日 | $-0.21 | $-0.35 | 39.9% | |
| 2025年12月31日 | $-0.34 | $-0.39 | 13.1% | |
| 2025年9月30日 | $-0.34 | $-0.42 | 18.2% | |
| 2025年6月30日 | $-0.30 | $-0.47 | 36.1% | |
| 2025年3月31日 | $-0.41 | $-0.49 | 17.1% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21M | $101M | $97M | $134M | $207M | $21M | $21M | $28M | |
| R&D Expense | $123M | $186M | $192M | $210M | $189M | $157M | $101M | $73M | |
| SG&A Expense | $54M | $60M | $57M | $61M | $55M | $59M | $35M | $12M | |
| Operating Expenses | $177M | $246M | $249M | $271M | $244M | $216M | $136M | $85M | |
| Operating Income | $-156M | $-145M | $-152M | $-138M | $-37M | $-195M | $-114M | $-57M | |
| Other Non-op | $13M | $26M | $27M | $8M | $1M | $5M | $9M | $5M | |
| Pretax Income | $-143M | $-119M | $-125M | $-130M | · | · | · | · | |
| Income Tax | $168.0K | $128.0K | $5M | $3M | $0 | $0 | $0 | · | |
| Net Income | $-143M | $-119M | $-130M | $-133M | $-36M | $-190M | $-105M | $-52M | |
| EPS (Basic) | $-1.39 | $-1.23 | $-1.56 | $-1.62 | $-0.45 | $-2.45 | · | · | |
| EPS (Diluted) | $-1.39 | $-1.23 | $-1.56 | $-1.62 | $-0.45 | $-2.45 | · | · | |
| Shares (Basic) | 102,998,978 | 96,588,177 | 83,733,730 | 82,467,587 | 80,416,936 | 77,758,806 | · | · | |
| Shares (Diluted) | 102,998,978 | 96,588,177 | 83,733,730 | 82,467,587 | 80,416,936 | 77,758,806 | · | · | |
| EBITDA | $-156M | $-145M | $-152M | $-138M | $-37M | · | $-114M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $66M | $33M | $75M | $154M | $329M | $50M | $90M | $65M | |
| Short-term Investments | $190M | $380M | $474M | $559M | $406M | $363M | $263M | $225M | |
| Prepaid Expense | $10M | $11M | $17M | $11M | $7M | $8M | $4M | $3M | |
| Current Assets | $266M | $425M | $566M | $726M | $750M | $422M | $357M | $293M | |
| PP&E (Net) | $11M | $17M | $22M | $26M | $27M | $30M | $34M | $11M | |
| PP&E (Gross) | $48M | $50M | $50M | $48M | $45M | $41M | $39M | $13M | |
| Accum. Depreciation | $37M | $33M | $28M | $23M | $17M | $11M | $5M | $2M | |
| Other Non-current Assets | $386.0K | $5M | $7M | $6M | $6M | $3M | $676.0K | $3M | |
| Total Assets | $293M | $468M | $622M | $788M | $815M | $488M | $422M | $308M | |
| Accounts Payable | $2M | $2M | $4M | $4M | $5M | $3M | $278.0K | $126.0K | |
| Accrued Liabilities | $19M | $29M | $30M | $28M | $27M | $23M | $18M | $8M | |
| Short-term Debt | $366.0K | $0 | · | · | · | · | · | · | |
| Current Liabilities | $70M | $125M | $178M | $94M | $140M | $68M | $62M | $48M | |
| Capital Leases | $17M | $24M | $30M | $35M | $40M | $44M | $41M | · | |
| Other Non-current Liabilities | $2M | $1M | $1M | $759.0K | $158.0K | $472.0K | $493.0K | $96.0K | |
| Total Liabilities | $263M | $342M | $488M | $573M | $514M | $221M | $227M | $195M | |
| Long-term Debt | $10M | $10M | · | · | · | · | · | · | |
| Total Debt | $10M | $9M | · | · | · | · | · | · | |
| Common Stock | $11.0K | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | $1.0K | |
| Paid-in Capital | $1.00B | $956M | $844M | $799M | $748M | $677M | $414M | $17M | |
| Retained Earnings | $-972M | $-829M | $-710M | $-580M | $-446M | $-410M | $-220M | $-114M | |
| AOCI | $166.0K | $261.0K | $184.0K | $-5M | $-943.0K | $614.0K | $142.0K | $-42.0K | |
| Stockholders' Equity | $31M | $127M | $134M | $214M | $301M | $268M | $195M | $-97M | |
| Liabilities + Equity | $293M | $468M | $622M | $788M | $815M | $488M | $422M | $308M | |
| Shares Outstanding | 110,362,581 | 99,085,888 | 84,879,693 | 82,895,718 | 81,986,192 | 79,316,261 | 69,052,873 | 13,764,829 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $5M | $6M | $6M | $6M | $6M | $4M | $1M | |
| Stock-based Comp | $27M | $39M | $43M | $46M | $41M | $31M | $16M | $7M | |
| Restructuring | $2M | $4M | $2M | · | · | · | · | · | |
| Operating Cash Flow | $-184M | $-230M | $-184M | $-20M | $299M | $-167M | $-99M | $127M | |
| CapEx | $41.0K | $1M | $2M | $4M | $3M | $5M | $15M | $2M | |
| Investing Cash Flow | $197M | $107M | $102M | $-159M | $-50M | $-105M | $-49M | $-224M | |
| Stock Issued | $20M | $71M | · | · | · | · | · | · | |
| Net Stock Activity | $20M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $20M | $82M | $3M | $5M | $30M | $232M | $172M | $131M | |
| Net Change in Cash | $33M | $-41M | $-80M | $-175M | $279M | $-40M | $24M | $34M | |
| Taxes Paid | $-880.0K | $-100.0K | · | · | · | · | · | · | |
| Free Cash Flow | $-184M | $-231M | $-187M | $-24M | $295M | · | $-115M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -741.3% | -144.1% | -156.3% | -103.2% | -18.0% | · | -539.2% | · | |
| Net Margin | -679.2% | -118.3% | -134.3% | -99.8% | -17.5% | · | -496.6% | · | |
| Pretax Margin | -678.4% | -118.2% | · | · | · | · | · | · | |
| EBITDA Margin | -741.3% | -144.1% | -156.3% | -103.2% | -18.0% | · | -539.2% | · | |
| ROA | -37.5% | -21.8% | -18.5% | -16.6% | -5.6% | · | -28.9% | · | |
| ROE | -280.7% | -96.9% | -87.9% | -57.0% | -11.4% | · | -51.0% | · | |
| ROIC | -387.2% | -106.6% | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.4 | 3.2 | 7.7 | 5.4 | · | 5.8 | · | |
| Quick Ratio | 3.7 | 3.3 | 3.1 | 7.6 | 5.3 | · | 5.7 | · | |
| Debt / Equity | 0.3 | 0.1 | · | · | · | · | · | · | |
| LT Debt / Equity | 0.3 | 0.1 | · | · | · | · | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | 0.1 | 0.2 | 0.3 | · | 0.1 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.28 | $1.28 | $1.58 | $2.62 | $3.79 | · | $2.82 | · | |
| Revenue / Share | $0.20 | $1.04 | $1.16 | $1.62 | · | · | · | · | |
| Cash Flow / Share | $-1.79 | $-2.38 | $-2.20 | $-0.25 | · | · | · | · | |
| Cash / Share | $0.60 | $0.33 | $0.88 | $1.88 | $4.15 | · | $1.30 | · | |
| EPS (TTM) | $-1.39 | $-1.23 | $-1.56 | $-1.62 | $-0.45 | $-2.45 | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -79.1% | 3.6% | -27.3% | -35.5% | 881.5% | · | · | · | |
| Revenue CAGR 3Y | -46.0% | -21.4% | 66.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | -0.05% | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $21M | $101M | $97M | $134M | $207M | $21M | $21M | $28M | |
| Net Income TTM | $-143M | $-119M | $-130M | $-133M | $-36M | $-190M | $-105M | $-52M | |
| Market Cap | $172M | $187M | $677M | $757M | $1.64B | · | $1.19B | · | |
| Enterprise Value | $-74M | $-217M | · | · | · | · | · | · | |
| P/E | -1.1 | -1.5 | -5.1 | -5.7 | -45.9 | -6.2 | · | · | |
| P/S | 8.2 | 1.9 | 7.0 | 5.7 | 7.9 | · | 56.1 | · | |
| P/B | 5.6 | 1.5 | 5.0 | 3.5 | 5.4 | · | 6.1 | · | |
| P / Tangible Book | 5.6 | 1.5 | 5.0 | 3.5 | 5.4 | 4.5 | · | · | |
| P / Cash Flow | -0.9 | -0.8 | -3.7 | -37.2 | 5.5 | · | -12.0 | · | |
| P / FCF | -0.9 | -0.8 | -3.6 | -31.0 | 5.5 | · | -10.4 | · | |
| EV / EBITDA | 0.5 | 1.5 | · | · | · | · | · | · | |
| EV / FCF | 0.4 | 0.9 | · | · | · | · | · | · | |
| EV / Revenue | -3.5 | -2.2 | · | · | · | · | · | · | |
| Earnings Yield | -89.1% | -65.1% | -19.6% | -17.5% | -2.2% | -16.2% | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $1M | $6M | $3M | $8M | $4M | $54M | $15M | $15M | $16M | $15M | $9M | $56M | $17M | $14M | $15M | |
| R&D Expense | $19M | $18M | $32M | $29M | $28M | $34M | $46M | $48M | $46M | $45M | $48M | $46M | $46M | $52M | $54M | $48M | |
| SG&A Expense | $8M | $8M | $13M | $12M | $14M | $15M | $15M | $16M | $14M | $14M | $15M | $13M | $14M | $15M | $15M | $14M | |
| Operating Expenses | $28M | $26M | $46M | $41M | $42M | $48M | $61M | $64M | $61M | $60M | $63M | $60M | $60M | $67M | $70M | $63M | |
| Operating Income | $-24M | $-25M | $-40M | $-38M | $-34M | $-45M | $-7M | $-48M | $-46M | $-44M | $-47M | $-51M | $-4M | $-50M | $-55M | $-48M | |
| Other Non-op | $2M | $2M | $2M | $3M | $4M | $4M | $5M | $6M | $7M | $8M | $8M | $7M | $6M | $5M | $4M | $2M | |
| Pretax Income | $-23M | $-23M | $-37M | $-35M | $-31M | $-40M | $-2M | $-42M | $-39M | $-36M | · | · | · | · | · | · | |
| Income Tax | $130.0K | $0 | $168.0K | $0 | $0 | $0 | $48.0K | $0 | $73.0K | $7.0K | $2M | $1M | $1M | $901.0K | $721.0K | $733.0K | |
| Net Income | $-23M | $-23M | $-37M | $-35M | $-31M | $-40M | $-2M | $-42M | $-39M | $-36M | $-41M | $-44M | $1M | $-46M | $-52M | $-46M | |
| EPS (Basic) | $-0.21 | $-0.21 | $-0.34 | $-0.34 | $-0.30 | $-0.41 | $-0.02 | $-0.43 | $-0.40 | $-0.38 | $-0.50 | $-0.53 | $0.02 | $-0.55 | $-0.64 | $-0.56 | |
| EPS (Diluted) | $-0.21 | $-0.21 | $-0.34 | $-0.34 | $-0.30 | $-0.41 | $-0.02 | $-0.43 | $-0.40 | $-0.38 | $-0.50 | $-0.53 | $0.02 | $-0.55 | $-0.64 | $-0.56 | |
| Shares (Basic) | 111,224,116 | 110,590,014 | · | 102,597,601 | 100,371,632 | 99,398,200 | · | 97,519,595 | 96,674,921 | 93,810,177 | · | 83,927,961 | 83,497,125 | 83,102,296 | · | 82,602,842 | |
| Shares (Diluted) | 111,224,116 | 110,590,014 | · | 102,597,601 | 100,371,632 | 99,398,200 | · | 97,519,595 | 96,674,921 | 93,810,177 | · | 83,927,961 | 83,566,293 | 83,102,296 | · | 82,602,842 | |
| EBITDA | $-24M | $-25M | · | $-38M | $-34M | $-45M | · | $-48M | $-46M | $-44M | · | $-51M | $-4M | $-50M | · | $-48M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $77M | $66M | $77M | $45M | $38M | $33M | $37M | $48M | $73M | $75M | $102M | $132M | $196M | · | $184M | |
| Short-term Investments | $113M | $130M | $190M | $215M | $263M | $317M | $380M | $420M | $456M | $490M | $474M | $487M | $499M | $474M | · | $574M | |
| Prepaid Expense | $7M | $9M | $10M | $9M | $12M | $12M | $11M | $12M | $16M | $19M | $17M | $14M | $10M | $12M | · | $10M | |
| Current Assets | $180M | $215M | $266M | $300M | $319M | $367M | $425M | $469M | $520M | $581M | $566M | $613M | $648M | $686M | · | $775M | |
| PP&E (Net) | $9M | $10M | $11M | $13M | $14M | $16M | $17M | $18M | $20M | $21M | $22M | $23M | $24M | $25M | · | $26M | |
| PP&E (Gross) | · | · | $48M | · | · | · | $50M | · | · | · | $50M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $37M | · | · | · | $33M | · | · | · | $28M | · | · | · | · | · | |
| Other Non-current Assets | $353.0K | $369.0K | $386.0K | $4M | $4M | $5M | $5M | $6M | $6M | $7M | $7M | $9M | $9M | $9M | · | $6M | |
| Total Assets | $203M | $240M | $293M | $335M | $356M | $408M | $468M | $516M | $571M | $635M | $622M | $672M | $709M | $748M | · | $837M | |
| Accounts Payable | $2M | $1M | $2M | $5M | $2M | $2M | $2M | $5M | $4M | $5M | $4M | $5M | $5M | $3M | · | $5M | |
| Accrued Liabilities | $7M | $11M | $19M | $18M | $14M | $17M | $29M | $26M | $23M | $19M | $30M | $30M | $23M | $19M | · | $23M | |
| Short-term Debt | · | $1M | $366.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $34M | $41M | $70M | $80M | $84M | $110M | $125M | $143M | $148M | $165M | $178M | $155M | $132M | $99M | · | $161M | |
| Capital Leases | $14M | $16M | $17M | $19M | $21M | $23M | $24M | $26M | $28M | $29M | $30M | $32M | $33M | $34M | · | $36M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $898.0K | $898.0K | $898.0K | · | $233.0K | |
| Total Liabilities | $213M | $230M | $263M | $278M | $285M | $314M | $342M | $397M | $420M | $457M | $488M | $510M | $512M | $565M | · | $584M | |
| Long-term Debt | $10M | · | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $10M | $10M | · | $10M | $10M | $9M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $11.0K | $11.0K | $11.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | · | $8.0K | |
| Paid-in Capital | $1.01B | $1.01B | $1.00B | $992M | $971M | $964M | $956M | $945M | $936M | $925M | $844M | $832M | $822M | $811M | · | $787M | |
| Retained Earnings | $-1.02B | $-995M | $-972M | $-935M | $-900M | $-870M | $-829M | $-827M | $-785M | $-746M | $-710M | $-669M | $-624M | $-626M | · | $-527M | |
| AOCI | $-126.0K | $-104.0K | $166.0K | $197.0K | $96.0K | $191.0K | $261.0K | $931.0K | $-620.0K | $-403.0K | $184.0K | $-721.0K | $-1M | $-2M | · | $-7M | |
| Stockholders' Equity | $-10M | $10M | $31M | $58M | $71M | $95M | $127M | $119M | $151M | $179M | $134M | $163M | $196M | $183M | $214M | $253M | |
| Liabilities + Equity | $203M | $240M | $293M | $335M | $356M | $408M | $468M | $516M | $571M | $635M | $622M | $672M | $709M | $748M | · | $837M | |
| Shares Outstanding | 111,656,805 | 111,025,187 | 110,362,581 | 107,446,056 | 101,212,329 | 99,992,600 | 99,085,888 | 97,929,897 | 97,321,062 | 96,384,562 | 84,879,693 | 84,136,381 | 83,830,300 | 83,351,778 | 82,895,718 | 81,986,192 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $2M | $984.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $3M | $3M | $5M | $6M | $7M | $8M | $10M | $9M | $10M | $10M | $12M | $10M | $10M | $11M | $11M | $11M | |
| Restructuring | $700.0K | $-300.0K | $100.0K | $-100.0K | $0 | $2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-34M | $-50M | $-42M | $-33M | $-49M | $-61M | $-55M | $-51M | $-63M | $-61M | $-46M | $-47M | $-43M | $-49M | $-49M | $-49M | |
| CapEx | $31.0K | $118.0K | $0 | $11.0K | $10.0K | $20.0K | $173.0K | $212.0K | $337.0K | $533.0K | $233.0K | $-94.0K | $1M | $1M | $766.0K | $2M | |
| Investing Cash Flow | $17M | $61M | $26M | $50M | $56M | $66M | $41M | $40M | $37M | $-12M | $18M | $17M | $-22M | $89M | $18M | $61M | |
| Stock Issued | · | · | $5M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $50.0K | $25.0K | $5M | $15M | $122.0K | $0 | $10M | $0 | $644.0K | $71M | $590.0K | $0 | $881.0K | $1M | $636.0K | $489.0K | |
| Net Change in Cash | $-17M | $11M | $-11M | $32M | $7M | $5M | $-4M | $-10M | $-25M | $-2M | $-27M | $-30M | $-64M | $41M | $-30M | $12M | |
| Free Cash Flow | · | $-50M | · | · | · | $-61M | · | · | · | $-62M | · | · | · | $-50M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -734.7% | -2382.3% | · | -1153.6% | -433.5% | -1208.0% | · | -315.7% | -302.4% | -275.0% | · | -555.3% | -6.4% | -302.8% | · | -321.5% | |
| Net Margin | -692.5% | -2192.2% | · | -1063.4% | -387.7% | -1093.8% | · | -275.2% | -256.4% | -227.0% | · | -488.2% | 2.5% | -277.1% | · | -310.7% | |
| Pretax Margin | -688.6% | -2192.2% | · | -1063.4% | -387.7% | -1094.6% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -734.7% | -2382.3% | · | -1153.6% | -433.5% | -1208.0% | · | -315.7% | -302.4% | -275.0% | · | -555.3% | -6.4% | -302.8% | · | -321.5% | |
| ROA | -8.2% | -7.1% | · | -8.1% | -6.6% | -7.8% | · | -7.1% | -6.0% | -5.2% | · | -5.9% | 0.17% | -5.4% | · | -5.5% | |
| ROE | -75.1% | -43.7% | · | -39.2% | -27.5% | -29.6% | · | -30.0% | -22.3% | -19.9% | · | -21.4% | 0.57% | -20.4% | · | -15.7% | |
| ROIC | 20108.0% | -123.7% | · | -55.9% | -42.3% | -43.0% | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | 5.3 | · | 3.8 | 3.8 | 3.3 | · | 3.3 | 3.5 | 3.5 | · | 3.9 | 4.9 | 6.9 | · | 4.8 | |
| Quick Ratio | 5.0 | 5.0 | · | 3.6 | 3.6 | 3.2 | · | 3.2 | 3.4 | 3.4 | · | 3.8 | 4.8 | 6.7 | · | 4.7 | |
| Debt / Equity | -1.0 | 0.9 | · | 0.2 | 0.1 | 0.1 | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.0 | 0.8 | · | 0.2 | 0.1 | 0.1 | · | · | · | · | · | · | · | · | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.09 | $0.09 | · | $0.54 | $0.70 | $0.95 | · | $1.21 | $1.55 | $1.86 | · | $1.93 | $2.34 | $2.20 | · | $3.09 | |
| Revenue / Share | $0.03 | $0.01 | · | $0.03 | $0.08 | $0.04 | · | $0.16 | $0.16 | $0.17 | · | $0.11 | $0.67 | $0.20 | · | $0.18 | |
| Cash Flow / Share | · | $-0.45 | · | · | · | $-0.61 | · | · | · | $-0.65 | · | · | · | $-0.58 | · | · | |
| Cash / Share | $0.54 | $0.69 | · | $0.71 | $0.44 | $0.38 | · | $0.38 | $0.49 | $0.75 | · | $1.21 | $1.57 | $2.35 | · | $2.25 | |
| EPS (TTM) | $-1.10 | $-1.19 | · | $-1.07 | $-1.16 | $-1.26 | · | $-1.71 | $-1.81 | $-1.39 | · | $-1.70 | $-1.73 | $-1.63 | · | $-1.66 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14M | $18M | · | $69M | $81M | $88M | · | $62M | $55M | $96M | · | $96M | $102M | $126M | · | $133M | |
| Net Income TTM | $-118M | $-125M | · | $-108M | $-115M | $-123M | · | $-158M | $-161M | $-121M | · | $-141M | $-143M | $-135M | · | $-136M | |
| Market Cap | $224M | $239M | · | $318M | $142M | $123M | · | $456M | $442M | $580M | · | $545M | $504M | $516M | · | $776M | |
| Enterprise Value | $61M | $42M | · | $37M | $-156M | $-222M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.8 | -1.8 | · | -2.8 | -1.2 | -1.0 | · | -2.7 | -2.5 | -4.3 | · | -3.8 | -3.5 | -3.8 | · | -5.7 | |
| P/S | 16.2 | 13.0 | · | 4.6 | 1.7 | 1.4 | · | 7.4 | 8.0 | 6.0 | · | 5.7 | 4.9 | 4.1 | · | 5.8 | |
| P/B | -22.5 | 23.0 | · | 5.5 | 2.0 | 1.3 | · | 3.8 | 2.9 | 3.2 | · | 3.4 | 2.6 | 2.8 | · | 3.1 | |
| P / Tangible Book | · | 23.0 | · | 5.5 | 2.0 | 1.3 | · | 3.8 | 2.9 | 3.2 | · | 3.4 | 2.6 | 2.8 | · | 3.1 | |
| P / Cash Flow | · | -4.8 | · | · | · | -2.0 | · | · | · | -9.5 | · | · | · | -10.6 | · | · | |
| EV / Revenue | 4.4 | 2.3 | · | 0.5 | -1.9 | -2.5 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -54.7% | -55.4% | · | -36.1% | -82.9% | -102.4% | · | -36.7% | -39.9% | -23.1% | · | -26.2% | -28.8% | -26.3% | · | -17.5% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $21M | $101M | $97M | $134M | $207M |
| 营业利润率 % | -741.3% | -144.1% | -156.3% | -103.2% | -18.0% |
| 净收入 | $-143M | $-119M | $-130M | $-133M | $-36M |
| 稀释后每股收益 (EPS) | $-1.39 | $-1.23 | $-1.56 | $-1.62 | $-0.45 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.3 | 0.1 | · | · | · |
| 流动比率 | 3.8 | 3.4 | 3.2 | 7.7 | 5.4 |
| 速动比率 | 3.7 | 3.3 | 3.1 | 7.6 | 5.3 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-184M | $-231M | $-187M | $-24M | $295M |
机构持有人 (13F) 154 家申报者 · $189.3M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
154
持有价值
$189.3M
新仓位
19
已退出持仓
8
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 19 (-10 与上一季度对比) | 8 (-10 与上一季度对比) | 59 (+15 与上一季度对比) | 34 (-2 与上一季度对比) | +4.1M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $20100000 | 10000000 | 10.62% | 股份 |
| BlackRock, Inc. | $15774236 | 7847879 | 8.33% | 股份 |
| VANGUARD GROUP INC | $10776564 | 6908054 | 5.69% | 股份 |
| Nantahala Capital Management, LLC | $8679399 | 4318109 | 4.58% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $8058773 | 4009340 | 4.26% | 股份 |
| Kynam Capital Management, LP | $7655073 | 3808494 | 4.04% | 股份 |
| Merck & Co., Inc. | $7126896 | 3545719 | 3.76% | 股份 |
| Balyasny Asset Management L.P. | $6527326 | 3247426 | 3.45% | 股份 |
| 683 Capital Management, LLC | $6432000 | 3200000 | 3.40% | 股份 |
| D. E. Shaw & Co., Inc. | $5949566 | 2959983 | 3.14% | 股份 |
| ADAR1 Capital Management, LLC | $5796002 | 2883583 | 3.06% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $5669191 | 2820493 | 2.99% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $4934077 | 2454271 | 2.61% | 股份 |
| Spruce Street Capital LP | $4223147 | 2101068 | 2.23% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $3997558 | 1988835 | 2.11% | 股份 |
| Ikarian Capital, LLC | $3985038 | 1982606 | 2.10% | 股份 |
| STATE STREET CORP | $3778328 | 1879765 | 2.00% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3549517 | 1765929 | 1.87% | 股份 |
| MEDICI CAPITAL LLC | $3321565 | 1652520 | 1.75% | 股份 |
| Affinity Asset Advisors, LLC | $3035100 | 1510000 | 1.60% | 股份 |
| Eversept Partners, LP | $2861985 | 1423873 | 1.51% | 股份 |
| FMR LLC | $2806759 | 1396398 | 1.48% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $2632249 | 1309577 | 1.39% | 股份 |
| Euclidean Capital LLC | $2628795 | 1307858 | 1.39% | 股份 |
| MACKENZIE FINANCIAL CORP | $2230638 | 1109770 | 1.18% | 股份 |
| DEUTSCHE BANK AG\ | $2207760 | 1098388 | 1.17% | 股份 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $2120936 | 1055192 | 1.12% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $2101206 | 1045376 | 1.11% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $1879684 | 935166 | 0.99% | 股份 |
| DAFNA Capital Management LLC | $1825786 | 908351 | 0.96% | 股份 |
| Elmind Capital, LP | $1809000 | 900000 | 0.96% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $1700458 | 845999 | 0.90% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1645850 | 818831 | 0.87% | 股份 |
| NORTHERN TRUST CORP | $1554659 | 773462 | 0.82% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1333820 | 663592 | 0.70% | 股份 |
| MARSHALL WACE, LLP | $1203105 | 598559 | 0.64% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1071029 | 532850 | 0.57% | 股份 |
| TWO SIGMA ADVISERS, LP | $1016808 | 651800 | 0.54% | 股份 |
| Balyasny Asset Management L.P. | $1012839 | 503900 | 0.53% | 买入期权 |
| New Leaf Venture Partners, L.L.C. | $1005124 | 339569 | 0.53% | 股份 |
| GOLDMAN SACHS GROUP INC | $872089 | 433875 | 0.46% | 股份 |
| XTX Topco Ltd | $803359 | 399681 | 0.42% | 股份 |
| CITADEL ADVISORS LLC | $786376 | 391232 | 0.42% | 股份 |
| CANTOR FITZGERALD, L. P. | $593939 | 295492 | 0.31% | 股份 |
| UBS Group AG | $550298 | 273780 | 0.29% | 股份 |
| Invesco Ltd. | $516849 | 257139 | 0.27% | 股份 |
| Bank of New York Mellon Corp | $502688 | 250093 | 0.27% | 股份 |
| AMERIPRISE FINANCIAL INC | $451305 | 224530 | 0.24% | 股份 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $402000 | 200000 | 0.21% | 股份 |
| LMR Partners LLP | $402000 | 200000 | 0.21% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×10 申报 | 2020年7月16日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 22 位内幕人士 · 11 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Arnon Rosenthal | Chief Executive Officer | 2026年9月3日 S | 2294600 | 0 | 4 | $-655369 |
| Neil Lindsay Berkley | CFO & Chief Business Officer | 2026年9月3日 S | 350649 | 0 | 4 | $-220535 |
| Marc Grasso | Chief Financial Officer | 2025年6月2日 S | 296072 | 0 | 0 | $0 |
| Sara Kenkare-Mitra | President and Head of R&D | 2025年12月3日 S | 501652 | 0 | 1 | $-46689 |
| Shehnaaz Suliman | President and COO | 2021年12月13日 M | 102598 | 0 | 0 | $0 |
| Grace Wong-Sarad | Principal Accounting Officer | 2026年9月4日 S | 106015 | 0 | 12 | $-99033 |
| Gary Romano | Chief Medical Officer | 2025年3月3日 S | 332977 | 0 | 0 | $0 |
| Robert King | Chief Development Officer | 2022年10月1日 A | 550871 | 0 | 0 | $0 |
| Robert Paul | Chief Medical Officer | 2021年8月9日 M | 234319 | 0 | 0 | $0 |
| Calvin Yu | Vice President, Finance | 2021年7月6日 M | 76686 | 0 | 0 | $0 |
| Sabah Oney | Chief Business Officer | 2020年10月1日 A | 573918 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | 董事 | 2026年6月17日 A | 118650 | 0 | 0 | $0 |
| Paula Hammond | 董事 | 2026年6月17日 A | 103609 | 0 | 0 | $0 |
| Kristine Yaffe | 董事 | 2026年6月17日 A | 124109 | 0 | 0 | $0 |
| Mark Altmeyer | 董事 | 2026年6月17日 A | 98650 | 0 | 0 | $0 |
| Richard H Scheller | 董事 | 2026年6月17日 A | 134899 | 0 | 0 | $0 |
| Louis J Lavigne JR | 董事 | 2026年6月17日 A | 128109 | 0 | 0 | $0 |
| Errol B Desouza | 董事 | 2026年6月17日 A | 98650 | 0 | 0 | $0 |
| David M. Wehner | 董事 | 2024年6月12日 A | 115330 | 0 | 0 | $0 |
| Terrance McGuire | 董事 | 2023年9月11日 S | 10853817 | 0 | 0 | $0 |
| Tillman U. Gerngross | 董事 | 2023年6月14日 A | 2644319 | 0 | 0 | $0 |
| GORDON CARL L | 董事 | 2019年5月10日 A | 203200 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 18 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.43% | 53037 SH | 2026年10月2日 | 每日 |
| UAE · iShares Trust | 0.41% | 3282337 SH | 2026年9月11日 | 每日 |
| IBRN · iShares Trust | 0.18% | 6349 SH | 2026年9月11日 | 每日 |
| IWC · iShares Trust | 0.05% | 336837 SH | 2026年9月11日 | 每日 |
| EEMS · iShares, Inc. | 0.02% | 212007 SH | 2026年9月11日 | 每日 |
| IWO · iShares Trust | 0.01% | 820921 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 152035 SH | 2026年10月2日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 563396 SH | 2026年8月19日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 94277 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.01% | 2501663 SH | 2026年9月11日 | 每日 |
| DFSU · Dimensional ETF Trust | 0.00% | 3867 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 16616 SH | 2026年9月3日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1071545 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2837922 SH | 2026年8月19日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9493 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5223 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.00% | 230061 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 160282 SH | 2026年9月11日 | 每日 |
ALEC 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 14 位分析师
买入
中位数目标
$2.00
+10.5%
3 21.4%
强烈买入
5 35.7%
买入
4 28.6%
持有
2 14.3%
卖出
0 0.0%
强烈卖出
12个月价格目标
5 位分析师 · 2026-10-02平均目标 $3.10 +71.3%
现在
当前价格 $1.81
最低$1.00
平均值$3.10
最高$6.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 6, 2026 申报